Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

The Good, the Bad, and the Ugly: PCI Public Reporting Needs Fine-tuning, Says SCAI

Todd Neale

October 20, 2016

News Daily News

Semaglutide Cuts Risk of Major Cardiovascular Events in Type 2 Diabetes: SUSTAIN-6

Michael O'Riordan

September 16, 2016

News Conference News ESC 2016

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

Shelley Wood

August 28, 2016

News Opinion Editor's Corner ACC 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Shelley Wood

April 13, 2016

News Daily News

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

Todd Neale

October 26, 2015

News Daily News

Nitrite Injection May Be Cardioprotective in STEMI Patients With Low TIMI Flow

February 25, 2015

News Daily News

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

Yael L. Maxwell

December 15, 2014

News Conference News AHA 2014

AVOIDing Oxygen in Suspected STEMI Tied to Smaller Infarcts, Less Recurrent MI

Yael L. Maxwell

November 18, 2014

News Daily News

血液透析滤过可降低患有肾及心脏功能障碍的ACS患者的死亡率

November 06, 2014

News Daily News

La Hemodiafiltración Reduce la Mortalidad en Pacientes SCA con Disfunción Renal y Cardíaca

November 06, 2014

News Daily News

Hemodiafiltration Lowers Mortality in ACS Patients With Renal, Cardiac Dysfunction

November 06, 2014

News Daily News

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

September 11, 2014

News Conference News ESC 2014

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

Caitlin E. Cox

September 01, 2014

News Daily News

NAC and/or Sodium Bicarbonate Fail to Add Protection Against Acute Kidney Damage in STEMI

Yael L. Maxwell

April 15, 2014

News Daily News

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

March 05, 2014

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

Presentation

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Presenter: M. Leoncini

October 09, 2013

News Daily News

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Yael L. Maxwell

May 13, 2013

News Conference News ACC 2013

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

L.A. McKeown

March 09, 2013

Advertisement

The Good, the Bad, and the Ugly: PCI Public Reporting Needs Fine-tuning, Says SCAI

Semaglutide Cuts Risk of Major Cardiovascular Events in Type 2 Diabetes: SUSTAIN-6

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

Nitrite Injection May Be Cardioprotective in STEMI Patients With Low TIMI Flow

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

AVOIDing Oxygen in Suspected STEMI Tied to Smaller Infarcts, Less Recurrent MI

血液透析滤过可降低患有肾及心脏功能障碍的ACS患者的死亡率

La Hemodiafiltración Reduce la Mortalidad en Pacientes SCA con Disfunción Renal y Cardíaca

Hemodiafiltration Lowers Mortality in ACS Patients With Renal, Cardiac Dysfunction

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

NAC and/or Sodium Bicarbonate Fail to Add Protection Against Acute Kidney Damage in STEMI

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content